Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
Michael B. VanElzakker, Sydney A. Brumfield, Paula S. Lara Mejia
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 751
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman, David A. Bluemke, Thomas F. Lüscher, et al.
European Heart Journal (2022) Vol. 43, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 540
Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis
Shin Jie Yong
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 4, pp. 573-580
Open Access | Times Cited: 214
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 173
A review of cytokine-based pathophysiology of Long COVID symptoms
Russell N. Low, Ryan Low, Athena Akrami
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 101
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Rahel S. König, Werner C. Albrich, Christian R. Kahlert, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 80
Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses
Warren P. Tate, Max Walker, Eiren Sweetman, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 74
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism
Maitray A. Patel, Michael J. Knauer, Michael Nicholson, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 72
Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures
Michael B. VanElzakker, Hannah F. Bues, Ludovica Brusaferri, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 713-723
Open Access | Times Cited: 21
The clinical value of cytokines in chronic fatigue syndrome
Tiansong Yang, Yan Yang, Delong Wang, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 88
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 511-511
Open Access | Times Cited: 38
Fighting Post-COVID and ME/CFS – development of curative therapies
Carmen Scheibenbogen, Judith Bellmann‐Strobl, Cornelia Heindrich, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 34
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort
Michael B. VanElzakker, Emma M. Tillman, Lael M. Yonker, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 6, pp. 603-609
Open Access | Times Cited: 25
The search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology
Krista S. P. Clarke, Caroline C. Kingdon, Michael Hughes, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Local Sleep and Alzheimer’s Disease Pathophysiology
Bryce A. Mander
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 69
Chronic fatigue syndrome: progress and possibilities
Carolina X. Sandler, Andrew R. Lloyd
The Medical Journal of Australia (2020) Vol. 212, Iss. 9, pp. 428-433
Closed Access | Times Cited: 58
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Klaus Wirth, Carmen Scheibenbogen, Friedemann Paul
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 53
The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure
Herbert Renz‐Polster, Marie‐Ève Tremblay, Dorothee Bienzle, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 35
Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Mehdi Aoun Sebaïti, Mathieu Hainselin, Yannick Gounden, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID
Warren P. Tate, Max Walker, Katie Peppercorn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5124-5124
Open Access | Times Cited: 20
The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives
Andreas Stallmach, Stefanie Quickert, Christian Puta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations
Betsy A. Keller, Candace N. Receno, Carl J. Franconi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Mitochondria and immunity in chronic fatigue syndrome
George Anderson, Michaël Maes
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 103, pp. 109976-109976
Closed Access | Times Cited: 48
Low-dose naltrexone as a treatment for chronic fatigue syndrome
Monica Bolton, Bryan Paul Chapman, Harm van Marwijk
BMJ Case Reports (2020) Vol. 13, Iss. 1, pp. e232502-e232502
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top